Grants

Fellowship Training Grant in Sleep Medicine The Department of Medical Affairs at Jazz Pharmaceuticals is pleased to announce the initiation of the Jazz Pharmaceuticals Fellowship Training Grant in Sleep Medicine. We are committed to helping advance the field of sleep medicine by supporting original research conducted by Fellows who are in training to become the next generation of sleep researchers and clinicians. We understand the difficulty in securing research support for fellowship trainees. To this end, Jazz Pharmaceuticals is launching a fellowship training grant program for trainees in accredited sleep training programs or complementary programs with an emphasis in sleep medicine. Applicants will be considered for one of four $50,000.00 grants, each for one year of support, to be awarded at the beginning of the 2008-2009 academic year. The work can be either clinical or basic science focused and use human or animal subjects, but should have clinical relevance and be primarily related to the field of sleep medicine. We expect the projects to be completed under an appropriate mentor in an accredited training program. Jazz Pharmaceuticals has assembled a Fellowship Grant Committee who will independently review all applications, and select the top four for funding. The Fellowship Grant Committee includes Thomas Roth, PhD (chair, Henry Ford Hospital), Dr. Emmanuel Mignot, MD, PhD (Stanford University), Antonio Culebras, MD (SUNY Upstate Medical University), Michael Bonnet, PhD (Wright State University), Janet Mullington, PhD (Harvard Medical School), Gary Richardson, MD (Henry Ford Hospital), David Rye, MD, PhD (Emory University), Helmut Schmidt, MD (Ohio Sleep Medicine Institute), Jonathan Schwartz, MD (University of Oklahoma), and Phyllis Zee, MD, PhD (Northwestern University). Applicants must submit a Letter of Intent by July 31, 2007. The Letter of Intent (1 page) should briefly describe the objectives of the proposed research and include the name of the proposed mentor. The Letter of Intent and Curriculum Vitae of the applicant should be mailed or emailed to: Julie Raithel, Medical Affairs Coordinator Jazz Pharmaceuticals, Inc. 3180 Porter Drive, Palo Alto, CA 94304 Email:julie.raithel@jazzpharma.com Letters of Intent will be reviewed by the Fellowship Grant Committee. Applicants will be notified of the Committee's decision by August 15, 2007, and if favorable, will be asked to submit a grant application. Grant applications must be received by October 1, 2007. Please download the grant application below: